75- Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Prognostic importance of baseline and serial
changes in microalbuminuria in patients with resistant hypertension. Atherosclerosis. 2011;
216:199–204. - De Nicola L, Gabbai FB, Agarwal R, Chiodini P, Borrelli S, Bellizzi V, et al. Prevalence and
prognostic role of resistant hypertension in chronic kidney disease patients. J Am Coll Cardiol.
2013;61:2461–7. - Irvin MR, Booth JN 3rd, Shimbo D, Lackland DT, Oparil S, Howard G, et al. Apparent
treatment- resistant hypertension and risk for stroke, coronary heart disease, and all-cause
mortality. J Am Soc Hypertens. 2014;8:405–13. - Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, et al. Treatment-
resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease:
results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
(ALLHAT). Hypertension. 2014;64:1012–21. - Sim JJ, Bhandari SK, Shi J, Reynolds K, Calhoun DA, Kalantar-Zadeh K, et al. Comparative
risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and
nonresistant hypertension. Kidney Int. 2015;88:622–32. - Kaboré J, Metzger M, Helmer C, Berr C, Tzourio C, Massy ZA, et al. Kidney function decline
and apparent treatment-resistant hypertension in the elderly. PLoS One. 2016;11:e0146056. - Verberk WJ, Kessels AGH, de Leeuw PW. Prevalence, causes, and consequences of masked
hypertension: a meta-analysis. Am J Hypertens. 2008;21:969–75. - Agarwal R, Pappas MK, Sinha AD. Masked uncontrolled hypertension in CKD. J Am Soc
Nephrol. 2016;27:924–32. - Bjorklundi K, Lind L, Zethelius B, Andren B, Lithell H. Isolated ambulatory hypertension
predicts cardiovascular morbidity in elderly men. Circulation. 2003;107:1297–302. - Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and clas-
sification of chronic kidney disease: a position statement from Kidney Disease: Improving
Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–100. - Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equa-
tion to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12. - Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported
measure of medication adherence. Med Care. 1986;24:67–74. - Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al. Spironolactone
versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant
hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386:
2059–68. - Carris NW, Smith SM. Quality of life in treatment-resistant hypertension. Curr Hypertens Rep.
2015;17:61.
5 Resistant Hypertension and Outcomes in Patients with and Without Chronic Kidney...